Dermatologists prescribe a range of medications for hair loss depending on the type, cause, and severity. The most common prescriptions fall into a few categories: hormone blockers that slow hair loss at the root cause, growth stimulators that push follicles into an active phase, anti-inflammatory drugs for autoimmune-related hair loss, and newer targeted therapies for severe cases. What you’re prescribed will depend largely on whether you’re dealing with pattern hair loss, an autoimmune condition like alopecia areata, or something else entirely.
Hormone Blockers for Pattern Hair Loss
The most widely prescribed medication for male pattern hair loss is finasteride, taken as a 1 mg daily pill. It works by blocking the conversion of testosterone into a more potent hormone that shrinks hair follicles over time. In clinical studies, men taking finasteride daily saw meaningful increases in both hair count and hair thickness over 24 weeks. The drug stabilizes loss in most men and produces visible regrowth in many.
Dutasteride is a stronger version of the same concept. It blocks the follicle-shrinking hormone more completely than finasteride does. At 0.5 mg, dutasteride taken three times per week produced hair count increases comparable to daily finasteride in a head-to-head pilot study, with results following a dose-dependent pattern. Dutasteride isn’t FDA-approved specifically for hair loss, so dermatologists prescribe it off-label, typically for men who haven’t responded well to finasteride.
Both medications carry a risk of sexual side effects. A meta-analysis of finasteride studies in men with pattern hair loss found the relative risk of sexual side effects was about 1.6 times higher than placebo. In practical terms, most men tolerate the drug without issues, but a subset experiences reduced libido or erectile changes that resolve after stopping the medication.
What Women Are Prescribed Instead
Finasteride and dutasteride are not used in women who could become pregnant because they can cause birth defects. Instead, dermatologists typically prescribe spironolactone for female pattern hair loss. Spironolactone blocks androgen activity at the follicle, reducing the hormonal signal that causes thinning. The most common starting dose is 50 mg twice daily, with an average treatment dose of 100 mg per day. Some women start lower at 25 mg twice daily and increase over time. A minimum of six months of consistent use is needed before results can be fairly evaluated.
For women who don’t respond to spironolactone, some dermatologists prescribe bicalutamide off-label at doses of 10 to 50 mg daily. This is a stronger androgen blocker originally developed for other purposes. It requires baseline liver function tests before starting and follow-up blood work every three to six months because of its potential impact on the liver.
Minoxidil: Topical and Oral
Minoxidil is the one treatment prescribed across nearly every type of hair loss, for both men and women. The over-the-counter topical versions (2% and 5% solutions or foam) are familiar to most people, but dermatologists increasingly prescribe low-dose oral minoxidil for patients who find topical application messy, irritating, or ineffective.
Cleveland Clinic dermatologists typically start patients on oral minoxidil at 0.625 to 1.25 mg daily, split from a 2.5 mg tablet. That’s a fraction of the dose used for its original purpose as a blood pressure medication, which is why the side effect profile at these low doses is generally mild. The most common side effect is unwanted hair growth on the face or body, affecting about 15% of patients. Systemic effects like lightheadedness, fluid retention, or a slightly faster heart rate occur in roughly 5.5% of patients.
Minoxidil works by increasing blood flow to follicles and pushing resting hairs back into a growth phase. It doesn’t address the hormonal cause of pattern hair loss, which is why dermatologists often prescribe it alongside a hormone blocker for a combined approach.
Compounded Topical Formulations
Rather than using separate products, many dermatologists now prescribe custom-compounded topical solutions that combine multiple active ingredients in one bottle. A common formulation includes 7% minoxidil, 0.1% finasteride, and 0.025% tretinoin (a vitamin A derivative) in a single solution applied to the scalp.
The finasteride component works locally at the follicle while minimizing the amount absorbed into the bloodstream, which can reduce the risk of systemic side effects compared to the oral pill. The tretinoin improves absorption of minoxidil through the skin, making it more effective than minoxidil alone. These compounded formulations require a prescription and are prepared by specialty pharmacies rather than being available off the shelf.
Treatments for Alopecia Areata
Alopecia areata is an autoimmune condition where the immune system attacks hair follicles, causing patchy or total hair loss. The treatment approach is completely different from pattern hair loss because the underlying problem is inflammation, not hormones.
For small patches, dermatologists commonly use steroid injections directly into the affected areas of the scalp. The standard concentration is 5 mg/mL for the scalp (lower concentrations of 2.5 mg/mL for facial areas like the beard or eyebrows), with sessions spaced about every six weeks. The maximum dose is typically 20 mg per monthly session. These injections suppress the local immune attack and allow follicles to recover. Most patients with limited patches respond well.
For severe alopecia areata affecting 50% or more of the scalp, the treatment landscape changed dramatically in 2022 and 2023 with the FDA approval of two oral medications in a class called JAK inhibitors. Baricitinib was approved in June 2022 as the first systemic treatment for severe alopecia areata, starting at 2 mg daily. Ritlecitinib followed in June 2023, approved for both adults and adolescents. These drugs work by blocking specific immune signaling pathways that drive the attack on hair follicles. Network meta-analyses show that both produce significant regrowth, with baricitinib at the higher 4 mg dose outperforming the 2 mg dose across multiple measures. Several other JAK inhibitors are in late-stage development and showing strong results as well.
What the Regrowth Timeline Looks Like
Regardless of which prescription you’re given, patience is non-negotiable. Most hair loss treatments follow a predictable timeline that can feel discouraging early on.
During months one and two, shedding may actually increase, especially with minoxidil. This temporary shedding phase happens because the medication pushes old, weakened hairs out to make room for new growth. You may notice very fine, short hairs beginning to appear. By months three and four, those fine hairs become more noticeable and some begin to thicken. Hair shaft diameter starts to improve.
Months five and six are when most people start seeing a difference in overall density. The new hairs are longer and thicker, and thinning areas begin to look fuller. The most significant visible improvement typically comes between months seven and twelve. This is why dermatologists emphasize sticking with treatment for a full year before deciding whether it’s working. For chronic conditions like pattern hair loss, ongoing treatment is necessary to maintain results. Stopping medication generally means the hair loss process resumes.
How Dermatologists Choose a Treatment Plan
Your dermatologist won’t just hand you a prescription based on symptoms alone. The first step is diagnosing the specific type of hair loss, which may involve a close examination of your scalp with a magnifying tool called a dermoscope, blood work to check for thyroid problems or nutritional deficiencies, and sometimes a small scalp biopsy.
For men with pattern hair loss, a typical first-line plan is oral finasteride plus topical or oral minoxidil. For women, it’s often spironolactone plus minoxidil. For alopecia areata with limited patches, steroid injections are usually tried first, with JAK inhibitors reserved for severe or widespread cases. Many dermatologists also layer in compounded topicals, platelet-rich plasma injections, or other adjunct treatments depending on the individual’s response over time. Treatment plans are frequently adjusted at follow-up visits as your dermatologist tracks progress and tolerability.